Research programme: alcoholism therapeutics - Lucid Psycheceuticals
Latest Information Update: 16 Feb 2023
At a glance
- Originator Lucid Psycheceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Alcoholism